by SRC | 24 Nov 2020 | BoMRA Updates
On the 19th of October 2020, BoMRA hosted a human medicine stakeholder meeting. This meeting was critical and was aimed at clearing the regulatory fog of human medicine in Botswana. The meeting brought light into both logistical and technical expectations of BoMRA...
by SRC | 9 Apr 2020 | BoMRA Updates, COVID-19
Yes, BoMRA has indicated that they will continue accepting, evaluating and registering human medicinal products during the COVID-19 lockdown. Submissions and all correspondence may only be sent electronically. Applicants may not submit samples until further notice....
by SRC | 1 Apr 2020 | BoMRA Updates, COVID-19
In response to three confirmed cases and one death due to COVID-19, and returning citizens and residents to Botswana from highly effected countries, President Masisi declared the State of Emergency. In his speech, he outlined the following: From April 2nd midnight,...
by SRC | 12 Mar 2020 | BoMRA Updates
This is an outline of BoMRA’s plan for the ongoing management of the medical supply chain and interactions with stakeholders during the COVID-19 pandemic. We recommend reading the entire publication. Please take special note of the following: All meetings...
by SRC | 6 Jan 2020 | BoMRA Updates
Since the introduction of the regulation of medicines in Botswana in 1993, almost all regulatory services have been free. The only paid service was the evaluation of dossiers which costed P500 per application. On the 06 of January 2020, BoMRA made an announcement of...
by SRC | 9 Aug 2019 | BoMRA Updates
For many years, counterfeit, unregistered and falsely labeled products have been populating the Botswana market. The market for authentic products was taken and replaced by adulterated products. This has been a concern to many prescribers, pharmacists, distributors...
